Audited Financial Results of the Company for the quarter and year ended March 31, 2026, is attached.
DRAGARWQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr Agarwal's Eye Hospital reported strong FY26 results with revenue from operations growing 18.6% YoY to ₹470.87 crore from ₹397.15 crore. Net profit after tax rose 28.3% to ₹70.10 crore versus ₹54.65 crore in the prior year. Q4 revenue stood at ₹120.01 crore with net profit of ₹16.24 crore. EBITDA for the full year was approximately ₹150.82 crore (31.5% margin), up from ₹123.09 crore (31% margin) in FY25. EPS improved to ₹147.02 per share from ₹116.28. The company recommended a final dividend of ₹4 per share, bringing total FY26 dividend to ₹7 per share (70%) including the ₹3 interim dividend already paid. Statutory auditors S.R. Batliboi & Associates issued an unmodified (clean) audit opinion. The Board also approved a scheme of amalgamation with holding company Dr. Agarwal's Health Care Limited, pending shareholder and regulatory approvals.
Strong financial performance with near 28% PAT growth and solid operating cash flows of ₹145 crore signals healthy business momentum. The 70% total dividend payout demonstrates shareholder-friendly policies. Clean audit opinion removes concerns about financial reporting quality, which is positive for investor confidence.